249 related articles for article (PubMed ID: 27261509)
1. DNMT1 Inhibition Reprograms Pancreatic Cancer Stem Cells via Upregulation of the miR-17-92 Cluster.
Zagorac S; Alcala S; Fernandez Bayon G; Bou Kheir T; Schoenhals M; González-Neira A; Fernandez Fraga M; Aicher A; Heeschen C; Sainz B
Cancer Res; 2016 Aug; 76(15):4546-58. PubMed ID: 27261509
[TBL] [Abstract][Full Text] [Related]
2. DNMT1-mediated methylation of BEX1 regulates stemness and tumorigenicity in liver cancer.
Wang Q; Liang N; Yang T; Li Y; Li J; Huang Q; Wu C; Sun L; Zhou X; Cheng X; Zhao L; Wang G; Chen Z; He X; Liu C
J Hepatol; 2021 Nov; 75(5):1142-1153. PubMed ID: 34217777
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic approach of Cancer stem cells (CSCs) in gastric adenocarcinoma; DNA methyltransferases enzymes in cancer targeted therapy.
Norollahi SE; Mansour-Ghanaei F; Joukar F; Ghadarjani S; Mojtahedi K; Gharaei Nejad K; Hemmati H; Gharibpoor F; Khaksar R; Samadani AA
Biomed Pharmacother; 2019 Jul; 115():108958. PubMed ID: 31075731
[TBL] [Abstract][Full Text] [Related]
4. DNMT1 Regulates Epithelial-Mesenchymal Transition and Cancer Stem Cells, Which Promotes Prostate Cancer Metastasis.
Lee E; Wang J; Yumoto K; Jung Y; Cackowski FC; Decker AM; Li Y; Franceschi RT; Pienta KJ; Taichman RS
Neoplasia; 2016 Sep; 18(9):553-66. PubMed ID: 27659015
[TBL] [Abstract][Full Text] [Related]
5. DNMT1 is essential for mammary and cancer stem cell maintenance and tumorigenesis.
Pathania R; Ramachandran S; Elangovan S; Padia R; Yang P; Cinghu S; Veeranan-Karmegam R; Arjunan P; Gnana-Prakasam JP; Sadanand F; Pei L; Chang CS; Choi JH; Shi H; Manicassamy S; Prasad PD; Sharma S; Ganapathy V; Jothi R; Thangaraju M
Nat Commun; 2015 Apr; 6():6910. PubMed ID: 25908435
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic cancer stem cells: A state or an entity?
Hermann PC; Sainz B
Semin Cancer Biol; 2018 Dec; 53():223-231. PubMed ID: 30130664
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of DNMT3A by miR-708-5p Inhibits Lung Cancer Stem Cell-like Phenotypes through Repressing Wnt/β-catenin Signaling.
Liu T; Wu X; Chen T; Luo Z; Hu X
Clin Cancer Res; 2018 Apr; 24(7):1748-1760. PubMed ID: 28972040
[No Abstract] [Full Text] [Related]
8. lncRNA
Li N; Yang G; Luo L; Ling L; Wang X; Shi L; Lan J; Jia X; Zhang Q; Long Z; Liu J; Hu W; He Z; Liu H; Liu W; Zheng G
Clin Cancer Res; 2020 Apr; 26(7):1736-1748. PubMed ID: 31831555
[TBL] [Abstract][Full Text] [Related]
9. Targeting epigenetic regulation of miR-34a for treatment of pancreatic cancer by inhibition of pancreatic cancer stem cells.
Nalls D; Tang SN; Rodova M; Srivastava RK; Shankar S
PLoS One; 2011; 6(8):e24099. PubMed ID: 21909380
[TBL] [Abstract][Full Text] [Related]
10. ISG15 is a critical microenvironmental factor for pancreatic cancer stem cells.
Sainz B; Martín B; Tatari M; Heeschen C; Guerra S
Cancer Res; 2014 Dec; 74(24):7309-20. PubMed ID: 25368022
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of PD2 leads to increased tumorigenicity and metastasis in pancreatic ductal adenocarcinoma.
Vaz AP; Deb S; Rachagani S; Dey P; Muniyan S; Lakshmanan I; Karmakar S; Smith L; Johansson S; Lele S; Ouellette M; Ponnusamy MP; Batra SK
Oncotarget; 2016 Jan; 7(3):3317-31. PubMed ID: 26689992
[TBL] [Abstract][Full Text] [Related]
12. Linc00511 acts as a competing endogenous RNA to regulate VEGFA expression through sponging hsa-miR-29b-3p in pancreatic ductal adenocarcinoma.
Zhao X; Liu Y; Li Z; Zheng S; Wang Z; Li W; Bi Z; Li L; Jiang Y; Luo Y; Lin Q; Fu Z; Rufu C
J Cell Mol Med; 2018 Jan; 22(1):655-667. PubMed ID: 28984028
[TBL] [Abstract][Full Text] [Related]
13. Association of increased DNA methyltransferase expression with carcinogenesis and poor prognosis in pancreatic ductal adenocarcinoma.
Zhang JJ; Zhu Y; Zhu Y; Wu JL; Liang WB; Zhu R; Xu ZK; Du Q; Miao Y
Clin Transl Oncol; 2012 Feb; 14(2):116-24. PubMed ID: 22301400
[TBL] [Abstract][Full Text] [Related]
14. MiR-10b inhibits migration and invasion of pancreatic ductal adenocarcinoma via regulating E2F7.
Xu C; Qi X
J Clin Lab Anal; 2020 Oct; 34(10):e23442. PubMed ID: 32592206
[TBL] [Abstract][Full Text] [Related]
15. Expression of cancer stem cell markers in pancreatic intraepithelial neoplasias and pancreatic ductal adenocarcinomas.
Kure S; Matsuda Y; Hagio M; Ueda J; Naito Z; Ishiwata T
Int J Oncol; 2012 Oct; 41(4):1314-24. PubMed ID: 22824809
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-181b-5p, ETS1, and the c-Met pathway exacerbate the prognosis of pancreatic ductal adenocarcinoma after radiation therapy.
Tomihara H; Yamada D; Eguchi H; Iwagami Y; Noda T; Asaoka T; Wada H; Kawamoto K; Gotoh K; Takeda Y; Tanemura M; Mori M; Doki Y
Cancer Sci; 2017 Mar; 108(3):398-407. PubMed ID: 28064436
[TBL] [Abstract][Full Text] [Related]
17. FoxO1-negative cells are cancer stem-like cells in pancreatic ductal adenocarcinoma.
Song W; Li Q; Wang L; Huang W; Wang L
Sci Rep; 2015 Jun; 5():10081. PubMed ID: 26068418
[TBL] [Abstract][Full Text] [Related]
18. Aberrant DNA methyltransferase expression in pancreatic ductal adenocarcinoma development and progression.
Gao J; Wang L; Xu J; Zheng J; Man X; Wu H; Jin J; Wang K; Xiao H; Li S; Li Z
J Exp Clin Cancer Res; 2013 Nov; 32(1):86. PubMed ID: 24423239
[TBL] [Abstract][Full Text] [Related]
19. The Role of lncRNAs in the Stem Phenotype of Pancreatic Ductal Adenocarcinoma.
Melendez-Zajgla J; Maldonado V
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34203589
[TBL] [Abstract][Full Text] [Related]
20. Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas.
Mees ST; Mardin WA; Sielker S; Willscher E; Senninger N; Schleicher C; Colombo-Benkmann M; Haier J
Ann Surg Oncol; 2009 Aug; 16(8):2339-50. PubMed ID: 19475450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
